Tryptophan Metabolism in Bladder Cancer Patients from Copenhagen

REFERENCES

• Alifano, A., Papa, S., Tancredi, F., Elicio, M. A. & Quagliariello, E. 1964. Tryptophan—nicotinic acid metabolism in patients with tumours of the bladder and kidney. Br J Cancer 18, 386.
   PubMed Web of Science ®Google Scholar
• Arend, R. A., Leklem, J. E. & Brown, R. R. 1970. Direct and steam distillation autoanalyzer methods for assay of diazotizable aromatic amine metabolites of tryptophan in urine and in serum. Biochem Med 4, 457.
   PubMed Web of Science ®Google Scholar
• Benassi, C. A., Perissinotto, B. & Allegri, G. 1963. The metabolism of tryptophan in patients with bladder cancer and other urological diseases. Clin Chim Acta 8, 822.
   PubMed Web of Science ®Google Scholar
• Bergkvist, A., Ljungqvist, A. & Moberger, G. 1965. Classification of bladder tumours based on the cellular pattern. Acta Chir Scand 130, 371.
   PubMedGoogle Scholar
• Boyland, E. & Williams, D. C. 1956. The metabolism of tryptophan in patients suffering from cancer of the bladder. Biochem J 64, 578.
   PubMed Web of Science ®Google Scholar
• Brown, R. R., Friedell, G. H. & Leklem, J. E. 1972. Tryptophan metabolism in patients with bladder cancer of occupational etiology. Am Indust Hyg Ass J 33, 217.
   PubMed Web of Science ®Google Scholar
• Brown, R. R., Price, J. M., Friedell, G. H. & Burney, S. W. 1969. Tryptophan metabolism in patients with bladder cancer: geographical differences. J Nat Cancer Inst 43, 295.
   PubMedGoogle Scholar
• Brown, R. R., Price, J. M., Satter, E. J. & Wear, J. B. 1960. The metabolism of tryptophan in patients with bladder cancer. Acta Unio Intern Contra Cancrum 16, 299.
   PubMedGoogle Scholar
• Bryan, G. T., Brown, R. R. & Price, J. M. 1964. Mouse bladder carcinogenecity of certain tryptophan metabolites and other aromatic nitrogen compounds suspended in cholesterol. Cancer Res 24, 596.
   PubMed Web of Science ®Google Scholar
• Bryan, G. T., Morris, C. P. & Brown, R. R. 1965. Absorption of 14C-labeled 4-hydroxy-L-kynurenine and 3-hydroxyanthranilic acid from the mouse urinary bladder under carcinogenic conditions. Cancer Res 25, 1432.
   PubMed Web of Science ®Google Scholar
• Clemmesen, J. 1977. Statistical studies in the aetiology of malignant neoplasms. V. Trends and Risks Denmark 1943–72. Acta Pathol Microbiol Scand, Suppl. 261.
   Google Scholar
• Cole, P. 1973. A population based study of bladder cancer. In Host environment interaction in the etiology of cancer in man (ed. R. Doll and I. Vodopija), pp. 83–87. International Agency for Research on Cancer, Lyon, France.
   Google Scholar
• Gailani, S., Murphy, G., Kenny, G., Nussbaum, A. & Silvernail, P. 1973. Studies on tryptophan metabolism in patients with bladder cancer. Cancer Res 33, 1071.
   PubMed Web of Science ®Google Scholar
• Lockwood, K. 1961. On the etiology of bladder tumors in København-Frederiksberg. Acta Pathol Microbiol Scand, Suppl. 145.
   Google Scholar
• Lower, G. T., Jr, Nilsson, T., Nelson, C. E., Wolf, H., Gamsky, T., Swaminathan, S. & Bryan, G. T. 1978. N-acetyltransferase phenotype in urinary bladder cancer: approaches in molecular epidemiology. Environ Health Perspec, in press.
   Google Scholar
• Price, J. M. & Brown, R. R. 1962. Studies on the etiology of carcinoma of the urinary bladder. Acta Unio Intern Contra Cancrum 18, 684.
   PubMedGoogle Scholar
• Radomski, J. L., Glass, E. M. & Deichmann, W. B. 1971. Transitional cell hyperplasia in the bladders of dogs fed DL-tryptophan. Cancer Res 31, 1690.
   PubMed Web of Science ®Google Scholar
• Radomski, J. L., Radomski, T. & MacDonald, W. E. 1977. Cocarcinogenic interaction between DL-tryptophan and 4-aminobiphenyl or 2-naphthylamine in dogs. J Natl Cancer Inst 58, 1831.
   PubMedGoogle Scholar
• Romas, N. A., Ionascu, L., Sholem, S., Ionascu, G. & Veenema, R. J. 1975. A new method for determination of urinary tryptophan metabolites in bladder carcinoma. J Urol 114, 223.
   PubMed Web of Science ®Google Scholar
• Röhl, L., Hochberg, K. & Kochen, W. 1969. Characteristic appearance of 3H-labeled-3-hydroxyanthranilic acid in the urinary bladder of rats with or without bladder tumours. Scand J Urol Nephrol 3, 214.
   PubMedGoogle Scholar
• Sundaresan, P. R. & Coursin, D. B. 1970. Microassay of pyridoxal phosphate using L-tyrosine-1-14C and tyrosine apodecarboxylase. Methods Enzymology 18, 509.
   Google Scholar
• Teulings, F. A. G., Fokkens, W., Kaalen, J. G. A. H. & van der Werf-Messing, B. 1973. The concentration of free and conjugated 3-hydroxyanthranilic acid in the urine of bladder tumour patients before and after therapy, measured with an enzymatic method. Br J Cancer 27, 316.
   PubMed Web of Science ®Google Scholar
• Teulings, F. A. G., Peters, H. A., Hop, W. C. J., Fokkens, W., Haije, W. G., Portengen, H. & van der Werf-Messing, B. 1978. A new aspect of the urinary excretion of tryptophan metabolites in patients with cancer of the bladder. Int J Cancer 21, 140.
   PubMed Web of Science ®Google Scholar
• Wolf, H. 1973. Studies on the role of tryptophan metabolites in the genesis of bladder cancer. Acta Chir Scand, Suppl. 433, 154.
   Google Scholar
• Wolf, H. 1974. Studies on tryptophan metabolism in man. The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway. Scand J Clin Invest, Suppl. 136.
   Google Scholar
• Wolf, H. & Brown, R. R. 1971. The effect of tryptophan load and vitamin B6 supplementation on urinary excretion of tryptophan metabolites in human male subjects. Clin Sci 41, 237.
   PubMed Web of Science ®Google Scholar
• Wolf, H., Brown, R. R. & Arend, R. A. 1978. The kynurenine load test. Scand J Clin Lab Invest, in press.
   Google Scholar
• Wolf, H., Brown, R. R. & Nyholm, K. 1975. Studies on tryptophan metabolism in Danish bladder cancer patients. Acta Vitamin Enzymol (Milano) 29, 117.
   PubMedGoogle Scholar
• Yess, N., Price, J. M., Brown, R. R., Swan, P. B. & Linkswiter, H. 1964. Vitamin B6 depletion in man: urinary excretion of tryptophan metabolites. J Nutr 84, 229.
   PubMed Web of Science ®Google Scholar